Areterna LLC, a Synthgene Company, and Medsol Corporation Sign Global Distribution Agreement
FOR IMMEDIATE RELEASE Areterna LLC, a subsidiary of Synthgene Biotech, established for the purpose of providing raw materials and services tailored to mRNA and oligonucleotide therapeutics, has entered into a global distribution agreement with Medsol Corporation, a...Areterna’s Caps and NTPs as Evaluated by a Customer
Areterna offers Cap Analogs, NTPs, and Modified NTPs for mRNA synthesis. Our products have been tested and accepted by over 200 companies worldwide. One of these companies shared with us how they decided to use our products.